Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells

Bertilsson, Göran ; Falk, Anna LU ; Frisén, Jonas ; Heidrich, Jessica ; Hellström, Kristina ; Kortesmaa, J ; Lindquist, Per ; Lundh, Hanna ; McGuire, Jacqueline and Mercer, Alex , et al. (2003) US Patent App. 10/291,171, 2003
Abstract
The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via PACAP, Maxadilan or VIP signaling. These methods are useful for reducing at least one symptom of the disorder.
Please use this url to cite or link to this publication:
inventor
Bertilsson, Göran ; LU ; Frisén, Jonas ; Heidrich, Jessica ; Hellström, Kristina ; Kortesmaa, J ; Lindquist, Per ; Lundh, Hanna ; McGuire, Jacqueline and Mercer, Alex , et al. (More)
Bertilsson, Göran ; LU ; Frisén, Jonas ; Heidrich, Jessica ; Hellström, Kristina ; Kortesmaa, J ; Lindquist, Per ; Lundh, Hanna ; McGuire, Jacqueline ; Mercer, Alex ; Patrone, Cesare ; Rönnholm, Harriet ; Wikström, Lilian and Zachrisson, Olof (Less)
publishing date
type
Patent
publication status
published
subject
patent number
US Patent App. 10/291,171, 2003
language
English
LU publication?
no
id
7b98ac8b-db2e-4845-9431-0210aad1bebc
alternative location
https://worldwide.espacenet.com/patent/search/family/027502712/publication/US2003165485A1?q=pn%3DUS2003165485A1
date added to LUP
2021-08-10 14:51:59
date last changed
2021-08-17 16:17:06
@misc{7b98ac8b-db2e-4845-9431-0210aad1bebc,
  abstract     = {{The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via PACAP, Maxadilan or VIP signaling. These methods are useful for reducing at least one symptom of the disorder.}},
  author       = {{Bertilsson, Göran and Falk, Anna and Frisén, Jonas and Heidrich, Jessica and Hellström, Kristina and Kortesmaa, J and Lindquist, Per and Lundh, Hanna and McGuire, Jacqueline and Mercer, Alex and Patrone, Cesare and Rönnholm, Harriet and Wikström, Lilian and Zachrisson, Olof}},
  language     = {{eng}},
  note         = {{Patent, Patent Number: US Patent App. 10/291,171, 2003}},
  title        = {{Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells}},
  url          = {{https://worldwide.espacenet.com/patent/search/family/027502712/publication/US2003165485A1?q=pn%3DUS2003165485A1}},
  year         = {{2003}},
}